Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Similar articles for PubMed (Select 24141347)

1.

A FRAX model for the estimation of osteoporotic fracture probability in Portugal.

Marques A, Mota A, Canhão H, Romeu JC, Machado P, Ruano A, Barbosa AP, Dias AA, Silva D, Araújo D, Simões E, Aguas F, Rosendo I, Silva I, Crespo J, Alves JD, Costa L, Mascarenhas M, Lourenço Ó, Ferreira PL, Lucas R, Roque R, Branco JC, Tavares V, Johansson H, Kanis J, Pereira da Silva JA.

Acta Reumatol Port. 2013 Apr-Jun;38(2):104-12.

PMID:
24141347
2.

Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures.

Lalmohamed A, Welsing PM, Lems WF, Jacobs JW, Kanis JA, Johansson H, De Boer A, De Vries F.

Osteoporos Int. 2012 Mar;23(3):861-9. doi: 10.1007/s00198-011-1852-2. Epub 2011 Nov 26.

3.

Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.

Leslie WD, Lix LM, Langsetmo L, Berger C, Goltzman D, Hanley DA, Adachi JD, Johansson H, Oden A, McCloskey E, Kanis JA.

Osteoporos Int. 2011 Mar;22(3):817-27. doi: 10.1007/s00198-010-1464-2. Epub 2010 Dec 16.

PMID:
21161509
4.

FRAX® probabilities and risk of major osteoporotic fracture in France.

Couris CM, Chapurlat RD, Kanis JA, Johansson H, Burlet N, Delmas PD, Schott AM.

Osteoporos Int. 2012 Sep;23(9):2321-7. doi: 10.1007/s00198-011-1883-8. Epub 2011 Dec 17.

PMID:
22179418
5.

Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.

Fraser LA, Langsetmo L, Berger C, Ioannidis G, Goltzman D, Adachi JD, Papaioannou A, Josse R, Kovacs CS, Olszynski WP, Towheed T, Hanley DA, Kaiser SM, Prior J, Jamal S, Kreiger N, Brown JP, Johansson H, Oden A, McCloskey E, Kanis JA, Leslie WD; CaMos Research Group.

Osteoporos Int. 2011 Mar;22(3):829-37. doi: 10.1007/s00198-010-1465-1. Epub 2010 Dec 16.

PMID:
21161508
6.

Updated fracture incidence rates for the Italian version of FRAX®.

Piscitelli P, Chitano G, Johannson H, Brandi ML, Kanis JA, Black DM.

Osteoporos Int. 2013 Mar;24(3):859-66. doi: 10.1007/s00198-012-2021-y. Epub 2012 May 26.

PMID:
22638710
7.

Incidence of hip fracture in Romania and the development of a Romanian FRAX model.

Grigorie D, Sucaliuc A, Johansson H, Kanis JA, McCloskey E.

Calcif Tissue Int. 2013 May;92(5):429-36. doi: 10.1007/s00223-013-9697-7. Epub 2013 Jan 19.

PMID:
23334302
8.

Development and application of FRAX in the management of osteoporosis in Ireland.

McGowan B, Kanis JA, Johansson H, Silke C, Whelan B.

Arch Osteoporos. 2013;8:146. doi: 10.1007/s11657-013-0146-z. Epub 2013 Aug 28.

PMID:
23982943
9.

Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.

Tamaki J, Iki M, Kadowaki E, Sato Y, Kajita E, Kagamimori S, Kagawa Y, Yoneshima H.

Osteoporos Int. 2011 Dec;22(12):3037-45. doi: 10.1007/s00198-011-1537-x. Epub 2011 Jan 29.

PMID:
21279504
10.

Incidence of hip fracture in Barranquilla, Colombia, and the development of a Colombian FRAX model.

Jaller-Raad JJ, Jaller-Char JJ, Lechuga-Ortiz JA, Navarro-Lechuga E, Johansson H, Kanis JA.

Calcif Tissue Int. 2013 Jul;93(1):15-22. doi: 10.1007/s00223-013-9717-7. Epub 2013 Mar 8.

PMID:
23471427
11.

Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study.

Ettinger B, Ensrud KE, Blackwell T, Curtis JR, Lapidus JA, Orwoll ES; Osteoporotic Fracture in Men (MrOS) Study Research Group.

Osteoporos Int. 2013 Apr;24(4):1185-93. doi: 10.1007/s00198-012-2215-3. Epub 2012 Nov 21.

12.

A systematic review of hip fracture incidence and probability of fracture worldwide.

Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C; IOF Working Group on Epidemiology and Quality of Life.

Osteoporos Int. 2012 Sep;23(9):2239-56. Epub 2012 Mar 15. Review.

13.

Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.

Leslie WD, Brennan SL, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA.

Arch Osteoporos. 2013;8:145. doi: 10.1007/s11657-013-0145-0. Epub 2013 Aug 9.

PMID:
23929269
14.

Guidance for the adjustment of FRAX according to the dose of glucocorticoids.

Kanis JA, Johansson H, Oden A, McCloskey EV.

Osteoporos Int. 2011 Mar;22(3):809-16. doi: 10.1007/s00198-010-1524-7. Epub 2011 Jan 13.

PMID:
21229233
15.

Updated fracture incidence rates for the US version of FRAX.

Ettinger B, Black DM, Dawson-Hughes B, Pressman AR, Melton LJ 3rd.

Osteoporos Int. 2010 Jan;21(1):25-33. doi: 10.1007/s00198-009-1032-9. Epub 2009 Aug 25.

16.

FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort.

Azagra R, Roca G, Encabo G, Aguyé A, Zwart M, Güell S, Puchol N, Gene E, Casado E, Sancho P, Solà S, Torán P, Iglesias M, Gisbert MC, López-Expósito F, Pujol-Salud J, Fernandez-Hermida Y, Puente A, Rosàs M, Bou V, Antón JJ, Lansdberg G, Martín-Sánchez JC, Díez-Pérez A, Prieto-Alhambra D.

BMC Musculoskelet Disord. 2012 Oct 22;13:204. doi: 10.1186/1471-2474-13-204.

17.

FRAX underestimates fracture risk in patients with diabetes.

Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA.

J Bone Miner Res. 2012 Feb;27(2):301-8. doi: 10.1002/jbmr.556.

PMID:
22052532
18.

Impact of changes in mortality on FRAX-derived fracture probabilities.

Kreidieh OI, El-Hajj Fuleihan G.

Bone. 2014 May;62:43-50. doi: 10.1016/j.bone.2014.01.014. Epub 2014 Jan 27.

PMID:
24480305
19.

Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort.

González-Macías J, Marin F, Vila J, Díez-Pérez A.

Bone. 2012 Jan;50(1):373-7. doi: 10.1016/j.bone.2011.11.006. Epub 2011 Nov 20.

PMID:
22129640
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk